In Silico Computational Screening of Kabasura Kudineer - Official Siddha Formulation and JACOM - Novel Herbal Coded Formulation Against SARS-CoV-2 Spike protein

52 Pages Posted: 13 Apr 2020

See all articles by Kiran Gangarapu

Kiran Gangarapu

School of Pharmacy, Anurag group of Institutions,

Sathiyarajeswaran P

Siddha Central Research Institute (CCRS)

Kanakavalli K

Central Council for Research in Siddha, Ministry of AYUSH

Kumar KM

Center for R&D Life Science, Department of Biotechnology, Dayananda Sagar University

Ramesh Kumar D

Salem Microbes Private Limited

Shreedevi MS

Siddha Central Research Institute (CCRS)

Karthik L

Salem Microbes Private Limited

Date Written: April 13, 2020

Abstract

Siddha Medicine is a valuable therapeutic choice which is classically used for treating viral respiratory infections, this principle of medicine is proven to contain antiviral compounds. In this study, we executed the molecular docking studies for Phytoconstituents of Siddha official formulation Kabasura Kudineer which is used in treating viral fever and respiratory diseases and a Novel Herbal Preparation - JACOM against the ongoing pandemic of novel coronavirus disease causative agent SARS-CoV-2 Spike protein. Further, we also conducted prediction studies on the pharmacokinetics (ADME) properties and the safety profile in order to identify the best drug candidates using pkCSM and SwissADME web servers. Totally 37 compounds were screened, of these 9 compounds showed high binding efficiency. Based on these, we proposed the new formulation called as “SNACK –V”.

Note: Funding: This work is supported by CCRS, Chennai and Salem microbes Private Ltd, Salem.

Conflict of Interest: The authors declare no Conflict of interest.

Ethical Approval: We not used any animals in the study and not carried out human trials. Hence, no need for ethical clearance.

Keywords: COVID-19, SARS-CoV-2 Spike protein, Kabasura Kudineer, JACOM, Molecular docking, ADMET, Siddha Medicine, SNACK-V

Suggested Citation

Gangarapu, Kiran and P, Sathiyarajeswaran and K, Kanakavalli and KM, Kumar and D, Ramesh Kumar and MS, Shreedevi and L, Karthik, In Silico Computational Screening of Kabasura Kudineer - Official Siddha Formulation and JACOM - Novel Herbal Coded Formulation Against SARS-CoV-2 Spike protein (April 13, 2020). Available at SSRN: https://ssrn.com/abstract=3574412 or http://dx.doi.org/10.2139/ssrn.3574412

Kiran Gangarapu

School of Pharmacy, Anurag group of Institutions, ( email )

Hyderabad
Telangana, 500038
India

Sathiyarajeswaran P

Siddha Central Research Institute (CCRS) ( email )

Chennai
Tamilnadu, TN 600106
India
600106 (Fax)

Kanakavalli K

Central Council for Research in Siddha, Ministry of AYUSH ( email )

Chennai
Chennai, TN TN 600106
India
600106 (Fax)

Kumar KM

Center for R&D Life Science, Department of Biotechnology, Dayananda Sagar University ( email )

Bangalore
Bangalore, Karnataka 560078
India

Ramesh Kumar D

Salem Microbes Private Limited ( email )

21/10C, Bajanai Madam Street
Gugai
Salem, TN TAMIL NADU 636 006
India
04272469928 (Phone)

Shreedevi MS

Siddha Central Research Institute (CCRS) ( email )

Chennai
Tamilnadu, TN 600106
India
600106 (Fax)

Karthik L (Contact Author)

Salem Microbes Private Limited ( email )

21/10C, Bajanai Madam Street
Gugai
Salem, TN TAMIL NADU 636 006
India
636 006 (Fax)

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
551
Abstract Views
2,351
rank
61,016
PlumX Metrics